Glycocalyx Therapeutics AG
Biotechnology-Research
Company Tagline
A company developing catalytic cancer immunotherapies
Industry Category
Business Keywords
Company Description
Glycocalyx Therapeutics AG is a pioneering biotechnology research company dedicated to developing transformative intratumoral pan-cancer therapies. Focusing on the tumor microenvironment, Glycocalyx Therapeutics AG aims to remove barriers and induce intratumoral immune architecture, facilitating effective full-circle immunotherapy. Their work involves the discovery, design, and engineering of catalytic immune effector systems.
Based in Basel, CH, Glycocalyx Therapeutics AG is committed to innovation in catalytic cancer immunotherapies. The company's research and development efforts are geared towards creating solutions that enhance the body's ability to fight cancer. Glycocalyx Therapeutics AG is poised to make significant contributions to the field of oncology through its cutting-edge approaches.
We invite the management of Glycocalyx Therapeutics AG to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and attract new opportunities.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
BioRay Pharmaceutical
Biotechnology-ResearchTo make a meaningful impact on people' s lives
Agena Bioscience
Biotechnology-ResearchA molecular diagnostics company dedicated to advancing the impact of genomics in healthcare and prec...
Link Cell Therapies
Biotechnology-ResearchA True CAR T Cell AND-Gate
ECM Therapeutics, Inc.
Biotechnology-ResearchRestoring health and functional tissues with extracellular matrix-based signaling molecules
Alternative Company Names
This company is also known as